Johnson Amp Johnson
latest news & developments
Africa needs a billion Covid vaccines, but supply is slowing down
Data collected by Unicef shows an alarming drop-off in shipments arriving in the continent since the start of 2022
More than 7-million expired Pfizer Covid-19 vaccines could be wasted by July
Vaccine hesitancy, corruption, and conspiracy theories and disinformation slow down uptake of Covid-19 vaccines
Wait, donate, demolish: Why millions of South Africa’s vaccines will never be used
Children aged five to 11 get smaller doses of the Pfizer vaccine than adults. That means the government will have to buy new vials to vaccinate this age group but the health…
Health department rolls out Pfizer boosters to eligible individuals
Low uptake anticipated because of festive season, but healthcare workers stand ready
How your body can protect you from getting sick with Omicron
Omicron’s many mutations allow it to duck our body’s natural defence, but the immune system has a some tricks to prevent you from getting severely ill
Ramaphosa returns to work after recovering from Covid-19
President Cyril Ramaphosa encourages citizens to vaccinate and continue to practice safety measures
Alarm as almost 20% of South Africa’s healthcare workers contract Covid
The 10-day healthcare worker ‘isolate and contact trace’ policy puts pressure on other healthcare workers and compromises hospitals’ ability to deliver quality healthcare
The ABCs of DIY vaccines: Why tech transfer is a big thing
A new World Health Organisation initiative is helping nations make their own vaccines, reducing their dependency on imports.
Immunocompromised finally prioritised for Covid-19 booster shots
Organ recipients are at greater risk of death from Covid-19, while waiting lists for transplants grow
SA teens, you’re next in the queue for a vaccine — no parental permission required
Teenagers between the ages of 12 and 17 will be able to register to receive their Covid-19 jab from 20 October. This group will be given only one dose of the Pfizer vaccine, for…
Advocates for ivermectin use severely flawed data
If ivermectin had dramatic results in combating Covid-19, it should perform well in any well-conducted, unbiased scientific study, but this is not the case
McKinsey did not tell the FDA it was working for opioid makers while also working for the agency
The consulting giant was helping Purdue Pharma and Johnson & Johnson fend off FDA regulations even as it helped shape FDA drug policy.
Africa in brief: 11-18 September
Your Africa updates: What happened on the continent this past week
J&J’s failure to deliver adequate Covid-19 doses to South Africa is nothing new
South Africa is still awaiting millions of Covid-19 vaccines from Johnson & Johnson even though the country contributed to its research through the Ensemble and Sisonke studies
How not to run a vaccine clinical trial – The Sputnik case study
Russia’s COVID vaccine, Sputnik V, is plagued by a series of red flags and question marks surrounding its clinical trials and results. Here’s how the jab took a shortcut and…